Stocks D, Thomas A, Finn A, Danon L, Brooks-Pollock E
J R Soc Interface. 2025; 22(222):20240445.
PMID: 39876790
PMC: 11775660.
DOI: 10.1098/rsif.2024.0445.
Hirano H, Asada H
J Med Case Rep. 2024; 18(1):631.
PMID: 39707550
PMC: 11660962.
DOI: 10.1186/s13256-024-04889-2.
Cheng R, Helmers A, Kreuser S, Dahl N, Honaker Y, Lopez C
Cell Rep Methods. 2024; 4(10):100878.
PMID: 39406231
PMC: 11573788.
DOI: 10.1016/j.crmeth.2024.100878.
Kim W
Immune Netw. 2024; 24(4):e28.
PMID: 39246619
PMC: 11377948.
DOI: 10.4110/in.2024.24.e28.
Rogers G, Huang C, Mathur A, Huang X, Chen H, Stanten K
Nat Biomed Eng. 2024; 8(12):1700-1714.
PMID: 39039240
DOI: 10.1038/s41551-024-01240-4.
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing.
Hill T, Narvekar P, Asher G, Edelstein J, Camp N, Grimm A
Mol Ther. 2024; 32(8):2676-2691.
PMID: 38959896
PMC: 11405176.
DOI: 10.1016/j.ymthe.2024.06.004.
Appropriate Sampling and Longer Follow-Up Are Required to Rigorously Evaluate Longevity of Humoral Memory After Vaccination.
Ganusov V
Immunohorizons. 2024; 8(6):397-403.
PMID: 38864816
PMC: 11220738.
DOI: 10.4049/immunohorizons.2300057.
A guide to adaptive immune memory.
Lam N, Lee Y, Farber D
Nat Rev Immunol. 2024; 24(11):810-829.
PMID: 38831162
DOI: 10.1038/s41577-024-01040-6.
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture.
Nguyen D, Saney C, Hentenaar I, Cabrera-Mora M, Capric V, Woodruff M
Sci Rep. 2024; 14(1):3616.
PMID: 38350990
PMC: 10864258.
DOI: 10.1038/s41598-024-53977-2.
New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells.
Fooksman D, Jing Z, Park R
Nat Rev Immunol. 2024; 24(7):461-470.
PMID: 38332373
DOI: 10.1038/s41577-024-00991-0.
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
Alexandre M, Prague M, McLean C, Bockstal V, Douoguih M, Thiebaut R
NPJ Vaccines. 2023; 8(1):174.
PMID: 37940656
PMC: 10632397.
DOI: 10.1038/s41541-023-00767-y.
Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder.
Matsuoka T, Araki M, Lin Y, Okamoto T, Gold R, Chihara N
Neurol Neuroimmunol Neuroinflamm. 2023; 11(1).
PMID: 37863660
PMC: 10691226.
DOI: 10.1212/NXI.0000000000200173.
SARS-CoV-2 spike-specific T cells exhibit unique responses in infected and vaccinated individuals.
He R, Zheng X, Zhang J, Liu B, Wang Q, Wu Q
Signal Transduct Target Ther. 2023; 8(1):393.
PMID: 37802996
PMC: 10558553.
DOI: 10.1038/s41392-023-01650-x.
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.
Dari A, Jacqmin P, Iwaki Y, Neyens M, Le Gars M, Sadoff J
CPT Pharmacometrics Syst Pharmacol. 2023; 12(10):1485-1498.
PMID: 37715342
PMC: 10583247.
DOI: 10.1002/psp4.13025.
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib.
Sgro D, Rossi P, Piaggi P, Brancatella A, Lorusso L, Bottici V
J Endocr Soc. 2023; 7(8):bvad084.
PMID: 37440964
PMC: 10334479.
DOI: 10.1210/jendso/bvad084.
Notch Signaling in Acute Inflammation and Sepsis.
Gallenstein N, Tichy L, Weigand M, Schenz J
Int J Mol Sci. 2023; 24(4).
PMID: 36834869
PMC: 9967996.
DOI: 10.3390/ijms24043458.
Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation.
Yang N, Maskey A, Srivastava K, Kim M, Wang Z, Musa I
Front Immunol. 2023; 14:1081121.
PMID: 36825019
PMC: 9941740.
DOI: 10.3389/fimmu.2023.1081121.
Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques.
Pampusch M, Sevcik E, Quinn Z, Davey B, Berg J, Gorrell-Brown I
Front Immunol. 2023; 14:1101446.
PMID: 36825014
PMC: 9941136.
DOI: 10.3389/fimmu.2023.1101446.
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy.
Azar J, Evans J, Sikorski M, Chakravarthy K, McKenney S, Carmody I
JCI Insight. 2023; 8(6).
PMID: 36749632
PMC: 10070099.
DOI: 10.1172/jci.insight.163434.
Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy.
Hill J, Kiem E, Bhatti A, Liu W, Keane-Candib J, Fitzpatrick K
Am J Transplant. 2023; 23(3):416-422.
PMID: 36748802
PMC: 10266802.
DOI: 10.1016/j.ajt.2022.11.001.